The International Myeloma Foundation Announces the Annual Miles for Myeloma 5K Run/Walk: 15 Years of Making a Difference in the Myeloma Community
03 avr. 2023 08h45 HE
|
International Myeloma Foundation
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park...
National Marrow Donor Program/Be The Match Continues to Invest in Researchers of Tomorrow and Expands its Philanthropically Funded Research Programs
16 mars 2023 16h08 HE
|
Be The Match
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match® announced two recipients of its Amy Strelzer Manasevit Research Program grant for 2023. The grant...
Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report 2023: A $2.3 Billion Market by 2030 - High Demand for Advanced Medicines and Implementation of International Standards by CROs
24 févr. 2023 06h43 HE
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Region, And Segment Forecasts,...
International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023
23 févr. 2023 08h45 HE
|
International Myeloma Foundation
STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to...
Chemotherapy At Home Services Market Research Report 2022: Strategic Partnerships and Collaborations Fueling Market Growth
03 févr. 2023 07h33 HE
|
Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Chemotherapy...
International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event
02 févr. 2023 08h45 HE
|
International Myeloma Foundation
BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and...
ASTCT to Present Distinguished Honors at the 2023 Tandem Meetings
17 janv. 2023 12h00 HE
|
American Society for Transplantation and Cellular Therapy
CHICAGO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) will present top awards to leaders in the field of transplantation and cellular therapy...
Mendus AB: Mendus presenterar positiva överlevnadsdata från ADVANCE II-studien, som utvärderar DCP-001 som underhållsbehandling vid AML, på American Society of Hematology (ASH)
12 déc. 2022 13h00 HE
|
Mendus AB
TISDAGEN DEN 13 DECEMBER 2022, KLOCKAN 8.00AM ET/2.00PM CET, GENOMFÖR MENDUS ETT WEBBSÄNT MÖTE, DÄR RESULTATEN SOM PRESENTERATS PÅ ASH KOMMER ATT DISKUTERAS Mendus AB (“Mendus” publ; IMMU.ST),...
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
12 déc. 2022 13h00 HE
|
Mendus AB
MENDUS TO HOST A WEBCAST TO DISCUSS THE ASH DATA ON TUESDAY, DECEMBER 13, 2022 AT 8.00AM ET/2.00PM CET Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies...
UM171 cell therapy demonstrates improved outcomes compared to cord and matched unrelated donor peripheral blood transplants in real-world setting
12 déc. 2022 08h25 HE
|
ExCellThera
MONTRÉAL, Dec. 12, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy...